vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.

CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $124.7M, roughly 1.1× SMITH & WESSON BRANDS, INC.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 1.5%, a 81.0% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -3.9%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs -4.8%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

CTRE vs SWBI — Head-to-Head

Bigger by revenue
CTRE
CTRE
1.1× larger
CTRE
$134.9M
$124.7M
SWBI
Growing faster (revenue YoY)
CTRE
CTRE
+59.0% gap
CTRE
55.1%
-3.9%
SWBI
Higher net margin
CTRE
CTRE
81.0% more per $
CTRE
82.5%
1.5%
SWBI
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
-4.8%
SWBI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CTRE
CTRE
SWBI
SWBI
Revenue
$134.9M
$124.7M
Net Profit
$111.3M
$1.9M
Gross Margin
24.3%
Operating Margin
3.3%
Net Margin
82.5%
1.5%
Revenue YoY
55.1%
-3.9%
Net Profit YoY
113.5%
-53.6%
EPS (diluted)
$0.52
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
SWBI
SWBI
Q4 25
$134.9M
$124.7M
Q3 25
$132.4M
$85.1M
Q2 25
$112.5M
$140.8M
Q1 25
$96.6M
$115.9M
Q4 24
$86.9M
$129.7M
Q3 24
$77.4M
$88.3M
Q2 24
$68.9M
$159.1M
Q1 24
$63.1M
$137.5M
Net Profit
CTRE
CTRE
SWBI
SWBI
Q4 25
$111.3M
$1.9M
Q3 25
$74.9M
$-3.4M
Q2 25
$68.5M
$8.6M
Q1 25
$65.8M
$2.1M
Q4 24
$52.1M
$4.5M
Q3 24
$33.4M
$-1.9M
Q2 24
$10.8M
$27.9M
Q1 24
$28.7M
$7.9M
Gross Margin
CTRE
CTRE
SWBI
SWBI
Q4 25
24.3%
Q3 25
25.9%
Q2 25
28.8%
Q1 25
24.1%
Q4 24
26.6%
Q3 24
27.4%
Q2 24
35.5%
Q1 24
28.7%
Operating Margin
CTRE
CTRE
SWBI
SWBI
Q4 25
3.3%
Q3 25
58.1%
-3.5%
Q2 25
61.3%
9.3%
Q1 25
4.1%
Q4 24
5.8%
Q3 24
43.0%
-1.7%
Q2 24
15.1%
17.4%
Q1 24
8.2%
Net Margin
CTRE
CTRE
SWBI
SWBI
Q4 25
82.5%
1.5%
Q3 25
56.6%
-4.0%
Q2 25
60.9%
6.1%
Q1 25
68.1%
1.8%
Q4 24
60.0%
3.5%
Q3 24
43.2%
-2.1%
Q2 24
15.6%
17.5%
Q1 24
45.6%
5.7%
EPS (diluted)
CTRE
CTRE
SWBI
SWBI
Q4 25
$0.52
$0.04
Q3 25
$0.35
$-0.08
Q2 25
$0.35
$0.19
Q1 25
$0.35
$0.05
Q4 24
$0.30
$0.10
Q3 24
$0.21
$-0.04
Q2 24
$0.07
$0.60
Q1 24
$0.22
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
SWBI
SWBI
Cash + ST InvestmentsLiquidity on hand
$198.0M
$22.4M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$363.2M
Total Assets
$5.1B
$548.6M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
SWBI
SWBI
Q4 25
$198.0M
$22.4M
Q3 25
$712.5M
$18.0M
Q2 25
$306.1M
$25.2M
Q1 25
$26.5M
$26.7M
Q4 24
$213.8M
$39.1M
Q3 24
$377.1M
$35.5M
Q2 24
$495.1M
$60.8M
Q1 24
$451.2M
$47.4M
Total Debt
CTRE
CTRE
SWBI
SWBI
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Q1 24
$595.9M
Stockholders' Equity
CTRE
CTRE
SWBI
SWBI
Q4 25
$4.0B
$363.2M
Q3 25
$4.0B
$364.4M
Q2 25
$3.3B
$372.5M
Q1 25
$2.9B
$366.9M
Q4 24
$2.9B
$371.5M
Q3 24
$2.4B
$380.0M
Q2 24
$1.9B
$399.9M
Q1 24
$1.7B
$376.4M
Total Assets
CTRE
CTRE
SWBI
SWBI
Q4 25
$5.1B
$548.6M
Q3 25
$5.1B
$554.6M
Q2 25
$4.7B
$559.6M
Q1 25
$3.9B
$578.9M
Q4 24
$3.4B
$587.4M
Q3 24
$2.9B
$571.3M
Q2 24
$2.7B
$577.4M
Q1 24
$2.3B
$570.6M
Debt / Equity
CTRE
CTRE
SWBI
SWBI
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
SWBI
SWBI
Operating Cash FlowLast quarter
$394.0M
$27.3M
Free Cash FlowOCF − Capex
$16.3M
FCF MarginFCF / Revenue
13.1%
Capex IntensityCapex / Revenue
8.8%
Cash ConversionOCF / Net Profit
3.54×
14.22×
TTM Free Cash FlowTrailing 4 quarters
$21.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
SWBI
SWBI
Q4 25
$394.0M
$27.3M
Q3 25
$100.9M
$-8.1M
Q2 25
$100.8M
$40.8M
Q1 25
$71.4M
$-9.8M
Q4 24
$244.3M
$-7.4M
Q3 24
$67.2M
$-30.8M
Q2 24
$53.0M
$43.7M
Q1 24
$48.8M
$25.2M
Free Cash Flow
CTRE
CTRE
SWBI
SWBI
Q4 25
$16.3M
Q3 25
$-12.4M
Q2 25
$33.5M
Q1 25
$-16.1M
Q4 24
$-10.7M
Q3 24
$-35.5M
Q2 24
$38.2M
Q1 24
$7.0M
FCF Margin
CTRE
CTRE
SWBI
SWBI
Q4 25
13.1%
Q3 25
-14.6%
Q2 25
23.8%
Q1 25
-13.9%
Q4 24
-8.3%
Q3 24
-40.2%
Q2 24
24.0%
Q1 24
5.1%
Capex Intensity
CTRE
CTRE
SWBI
SWBI
Q4 25
8.8%
Q3 25
5.0%
Q2 25
5.2%
Q1 25
5.4%
Q4 24
2.5%
Q3 24
5.3%
Q2 24
3.5%
Q1 24
13.2%
Cash Conversion
CTRE
CTRE
SWBI
SWBI
Q4 25
3.54×
14.22×
Q3 25
1.35×
Q2 25
1.47×
4.73×
Q1 25
1.08×
-4.68×
Q4 24
4.68×
-1.63×
Q3 24
2.01×
Q2 24
4.92×
1.57×
Q1 24
1.70×
3.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons